Search results
Is Intrepid Potash (IPI) Stock Undervalued Right Now?
Zacks via Yahoo Finance· 2 years agoHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and...
Is Most-Watched Stock Intrepid Potash, Inc (IPI) Worth Betting on Now?
Zacks via Yahoo Finance· 2 years agoIntrepid Potash (IPI) has been one of the most searched-for stocks on Zacks.com lately. So, you...
Zacks.com featured highlights include Intrepid Potash, Fortrea Holdings and Cricut
Zacks via Yahoo Finance· 8 months agoFor Immediate Release Chicago, IL – September 18, 2023 – Stocks in this week’s article are Intrepid...
Fomento Economico Mexicano SAB de CV (FMX): A Strong Contender in the Alcoholic Beverages ...
GuruFocus.com via Yahoo Finance· 9 months agoFomento Economico Mexicano SAB de CV (NYSE:FMX), a leading player in the alcoholic beverages...
FDA Approves Roche's Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma
Benzinga via Yahoo Finance· 1 year agoThe FDA has approved Roche Group AG's (OTC: RHHBY) Genentech's Polivy (polatuzumab vedotin-piiq) in...
EU investigates fair access to China's medical device market
Reuters via Yahoo News· 1 week agoBRUSSELS (Reuters) -The European Commission launched a probe into China's public procurement of...
EU launches probe of China’s medical device market
MedTech Dive via Yahoo Finance· 1 week agoThe European Commission said Wednesday it has initiated an investigation into how China procures medical devices in the public market, alleging unfair...
EU Set to Launch China Probe on Medical Device Procurement
Bloomberg via Yahoo News· 3 weeks ago(Bloomberg) -- The European Union is set to launch an investigation into China’s procurement of...
Roche (RHHBY) Polivy Combination for DLBCL Gets Full Approval
Zacks via Yahoo Finance· 1 year agoRoche (RHHBY) gets full approval for Polivy (polatuzumab vedotin-piiq) in combination with Rituxan,...
MorphoSys AG (NASDAQ:MOR) Q3 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoMorphoSys AG (NASDAQ:MOR) Q3 2022 Earnings Call Transcript November 17, 2022 Operator: Ladies and...